-
Policy Critique: Ueda et al. On Japan’s COVID-19 Vaccine Public Health Response
Editorial This issue features the third entry in a growing category of peer-reviewed scholarship in Science, Public Health Policy & the…
-
MAHA Movement Flabbergasted COVID-19 Vaccines Remain on Market
By Peter A. McCullough, MD, MPH The recent Senate hearing on COVID-19…
-
The Biosecurity Industry Fights Back: national security is at stake without our mRNA vaccines. Here is all you need to see this is utter fabrication
Here is why a chorus insists that mRNA vaccines are a military…
-
Hantavirus: Market versus Government Disease Control
Pandemics offer an alleged challenge to libertarians, as some argue that governments…
Editor’s Choice
About the Journal
This initiative exists to help insure that policies in public health practice and law are founded on a full consideration of available knowledge derived by robust science. From Dr Lyons-Weiler: “While IPAK will continue to conduct basic, clinical and translational biomedical research in a completely unbiased manner, and will pubish results regardless of the outcome, it will also be increasingly centered on questions of policy and law that impact public health, laws that impact public health, and cases and rulings that impact the citizen’s expression of self-governance through law. We’re putting the Public back into Public Health.”